Statins for the prevention of primary venous thromboembolism-Reference-Cited by-同舟云学术

Statins for the prevention of primary venous thromboembolism

Published:2021-06-28 Issue:6 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Zhang Peng¹,Li Lun²,Tian JinHui³,Zhang Peizhen⁴,Yang KeHu⁵

Affiliation:

1. Department of Pediatric Surgery; Nanyang Central Hospital; Nanyang China

2. Department of Breast Surgery; The Second Xiangya Hospital, Central South University; Changsha China

3. Evidence-Based Medicine Center, School of Basic Medical Sciences; Lanzhou University; Lanzhou City China

4. Maternity and Child-care; Hospital of Lanzhou City; Lanzhou City China

5. Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province; Lanzhou University; Lanzhou City China

Publisher

Wiley

Subject

Pharmacology (medical)

Reference71 articles.

1. Cardiovascular risk factors and venous thromboembolism: a meta-analysis;Ageno;Circulation,2008

2. Effect of statin therapy on C-reactive protein levels: the pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study;Albert;Journal of the American Medical Association,2001

3. Secular trends in incidence and mortality of acute venous thromboembolism: the AB-VTE population-based study;Alotaibi;American Journal of Medicine,2016

4. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction;Alpert;Journal of the American College of Cardiology,2001

5. Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population;Arshad;European Journal of Epidemiology,2017